Quarterly report pursuant to Section 13 or 15(d)

Consolidated Condensed Balance Sheets

v3.21.2
Consolidated Condensed Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Current assets:    
Cash and cash equivalents $ 194,942 $ 5,098
Restricted cash 2,730 5,475
Accounts receivable, net of allowance of $0 and $0, respectively 4,909 2,903
Prepaid expenses and other current assets 5,481 965
Contract assets 2,313 3,796
Total current assets 210,375 18,237
Property and equipment - net 21,703 20,852
Goodwill 9,393 9,393
Investment in equity method investees 4,070 3,277
Intangible assets - net 2,817 3,831
Satellite procurement work in process 73,758 62,664
Other assets 1,556 1,661
Total assets 323,672 119,915
Current liabilities:    
Accounts payable and accrued liabilities 10,240 7,966
Amounts payable to equity method investees 0 8,762
Contract liabilities - current 14,453 14,537
Debt - current portion 0 16,739
Other current liabilities 2,701 7,439
Total current liabilities 27,394 55,443
Liability for estimated contract losses 7,637 6,252
Other liabilities 5,166 3,605
Long-term contract liabilities 683 2,559
Derivative liabilities 51,973 0
Long-term debt - net of current portion 78,022 84,869
Total liabilities 170,875 152,728
Commitments and contingencies (Note 21)
Stockholders’ equity:    
Preferred stock, $0.0001 par value; 100,000 shares authorized; none issued and outstanding. 0 0
Class A common stock, $0.0001 par value-authorized, 300,000 and 65,169 shares; issued, 116,116 and 35,582 shares; outstanding, 113,324 shares and 34,692 shares as of September 30, 2021 and December 31, 2020, respectively. 11 3
Additional paid-in capital 629,090 191,168
Retained earnings (476,304) (223,984)
Total stockholders’ equity 152,797 (32,813)
Total liabilities and stockholders’ equity $ 323,672 $ 119,915